|
KMID : 0361020210640080554
|
|
Korean Journal of Otolaryngology - Head and Neck Surgery
2021 Volume.64 No. 8 p.554 ~ p.562
|
|
|
Cost-Effectiveness Analysis of Immunotherapy in Patient with Allergic Rhinitis
|
|
Park Joon-Yong
Kim Yoon-Sook
Kim Jin-Kook
Cho Jae-Hoon
|
|
|
Abstract
|
|
|
Background and Objectives All treatments must be effective and affordable. Although itis clear that immunotherapy is effective in patients with allergic rhinitis, no cost-effectivenessanalysis has been conducted in Korea.
Subjects and Method We compared 10 years of total treatment costs (medical expense+transportation cost+time cost) with medications and symptoms scores assuming that adult patientswith allergic rhinitis are treated only with symptomatic medication (medication model)or immunotherapy (subcutaneous or sublingual) plus symptomatic medication [subcutaneousimmunotherapy (SCIT) and sublingual immunotherapy (SLIT) models, respectively]. Forcost-effectiveness analysis, related papers and domestic medical statistics were used.
Results The total treatment costs for the first 3 years were \3330199, \6605557, and\7130467 for the Medication model, SCIT model and SLIT model, respectively. The totaltreatment costs for the 10-year period were \7996087, \8588624, and \9113534 for themedication model, SCIT model, and SCIT model, respectively. The cumulative symptomsplus medications scores decreased 0.44 times in both immunotherapy models compared to themedication model.
Conclusion The initial cost of immunotherapy is more expensive than symptomatic medication,but the total cost for 10 years is similar. In addition, immunotherapy can reduce symptomsby more than half. Therefore, it is a cost-effective treatment for allergic rhinitis.
|
|
|
KEYWORD
|
|
|
Allergic rhinitis, Cost-effectiveness analysis, Immunotherapy
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|